The Drug Administration of Vietnam under the Ministry of Health has given the green light to Vimedimex Medi-Pharma JSC to import 30 million doses of the Hayat-Vax vaccine, produced in China and packaged in the UAE.
Vimedimex had earlier proposed importing the vaccine to meet the urgent demand for the pandemic prevention and control in Vietnam, Lao Dong newspaper reported.
The vaccine is made by China’s Beijing Institute of Biological Products Co., Ltd (Sinopharm) and packaged by the UAE’s Gulf Pharmaceutical Industries (Julphar).
The Drug Administration of Vietnam required the vaccine batch to meet the requirements attached to a decision approving the Hayat-Vax vaccine.
Vimedimex was also asked to take responsibility for the origin and quality of the vaccine and ensure the safe and effective use of the vaccine for the right purpose.
The company must also comply with prevailing regulations on the vaccine import and distribution and other relevant regulations.
The Ministry of Health approved the Hayat-Vax vaccine for emergency use on September 10, making it the seventh COVID vaccine to get emergency use authorization in Vietnam.
On September 17, the ministry approved Cuba’s Abdala COVID-19 vaccine for emergency use in Vietnam.
The six other vaccines are AstraZeneca, Pfizer, Sputnik V, Moderna, Johnson & Johnson’s Janssen, and Sinopharm’s Vero Cell.